{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:04:28Z","timestamp":1789603468705,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002767","name":"China Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2025JK2120"],"award-info":[{"award-number":["2025JK2120"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011496","name":"Changsha Science and Technology Bureau","doi-asserted-by":"publisher","award":["kq2403032"],"award-info":[{"award-number":["kq2403032"]}],"id":[{"id":"10.13039\/501100011496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172980"],"award-info":[{"award-number":["82172980"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103675"],"award-info":[{"award-number":["82103675"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030087"],"award-info":[{"award-number":["82030087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874200"],"award-info":[{"award-number":["81874200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2021CFB086"],"award-info":[{"award-number":["2021CFB086"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021JC0002"],"award-info":[{"award-number":["2021JC0002"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ50645"],"award-info":[{"award-number":["2025JJ50645"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024JJ5607"],"award-info":[{"award-number":["2024JJ5607"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021JJ31069"],"award-info":[{"award-number":["2021JJ31069"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024JJ9133"],"award-info":[{"award-number":["2024JJ9133"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022RC1019"],"award-info":[{"award-number":["2022RC1019"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022SK2041"],"award-info":[{"award-number":["2022SK2041"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022JJ30073"],"award-info":[{"award-number":["2022JJ30073"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013050","name":"Guangdong Provincial Applied Science and Technology Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.apsb.2026.07.016","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:28:36Z","timestamp":1784179716000},"page":"6045-6065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the SETD2\u2013FTO\u2013KIT pathway as a pharmacological strategy for TKI-refractory GIST"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7166-9874","authenticated-orcid":false,"given":"Zhi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junju","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anfeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoxian","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengyi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuezhen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunquan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.07.016_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.annonc.2021.09.005","article-title":"Gastrointestinal stromal tumours: ESMO\u2013EURACAN\u2013GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up","volume":"33","author":"Casali","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.apsb.2026.07.016_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00254-5","article-title":"Gastrointestinal stromal tumours","volume":"7","author":"Blay","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.apsb.2026.07.016_bib3","doi-asserted-by":"crossref","first-page":"9495","DOI":"10.1038\/s41467-024-53821-1","article-title":"Genomic and transcriptomic landscape of human gastrointestinal stromal tumors","volume":"15","author":"Xie","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.016_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41571-022-00606-4","article-title":"New treatment strategies for advanced-stage gastrointestinal stromal tumours","volume":"19","author":"Klug","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2026.07.016_bib5","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.22.00294","article-title":"Ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor after treatment with imatinib (INTRIGUE): a randomized, open-label, phase III trial","volume":"40","author":"Bauer","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2026.07.016_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.apsb.2023.09.015","article-title":"A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance","volume":"14","author":"Sun","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.07.016_bib7","first-page":"166690","article-title":"Co-targeting of ACK1 and KIT triggers additive anti-proliferative and -migration effects in imatinib-resistant gastrointestinal stromal tumors","volume":"2023","author":"He","year":"1869","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.apsb.2026.07.016_bib8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nature09409","article-title":"ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours","volume":"467","author":"Chi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.016_bib9","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1158\/2159-8290.CD-21-0646","article-title":"MOZ and Menin-MLL complexes are complementary regulators of chromatin association and transcriptional output in gastrointestinal stromal tumor","volume":"12","author":"Hemming","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2026.07.016_bib10","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105977","article-title":"m6A RNA methylation: from mechanisms to therapeutic potential","volume":"40","author":"He","year":"2021","journal-title":"EMBO J"},{"key":"10.1016\/j.apsb.2026.07.016_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01510-2","article-title":"m6A modification: recent advances, anticancer targeted drug discovery and beyond","volume":"21","author":"Deng","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2026.07.016_bib12","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.apsb.2022.01.003","article-title":"Detailed resume of RNA m6A demethylases","volume":"12","author":"Shen","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.07.016_bib13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.trecan.2022.02.010","article-title":"FTO in cancer: functions, molecular mechanisms, and therapeutic implications","volume":"8","author":"Li","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.apsb.2026.07.016_bib14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41422-018-0097-4","article-title":"A dynamic N6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors","volume":"28","author":"Yan","year":"2018","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2026.07.016_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2022.01.008","article-title":"N6-Methyladenosine modification regulates imatinib resistance of gastrointestinal stromal tumor by enhancing the expression of multidrug transporter MRP1","volume":"530","author":"Xu","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2026.07.016_bib16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41418-022-01107-8","article-title":"N6-Methyladenosine-modified USP13 induces pro-survival autophagy and imatinib resistance via regulating the stabilization of autophagy-related protein 5 in gastrointestinal stromal tumors","volume":"30","author":"Gao","year":"2023","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.apsb.2026.07.016_bib17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.apsb.2021.08.028","article-title":"A novel inhibitor of N6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities","volume":"12","author":"Xie","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.07.016_bib18","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1016\/j.apsb.2024.07.016","article-title":"Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy","volume":"14","author":"Liu","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.07.016_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO suppresses cancer stem cell maintenance and immune evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2026.07.016_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF00173538","article-title":"Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone","volume":"346","author":"Nissinen","year":"1992","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.apsb.2026.07.016_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7116","article-title":"Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1","volume":"11","author":"Peng","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2026.07.016_bib22","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1158\/1078-0432.CCR-10-2180","article-title":"Gene expression signature-based prognostic risk score in gastric cancer","volume":"17","author":"Cho","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.07.016_bib23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1074\/mcp.RA119.001361","article-title":"Proteomic maps of human gastrointestinal stromal tumor subgroups","volume":"18","author":"Liu","year":"2019","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.apsb.2026.07.016_bib24","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1158\/1078-0432.CCR-20-1706","article-title":"Gastrointestinal stromal tumor: challenges and opportunities for a new decade","volume":"26","author":"Serrano","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.07.016_bib25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.apsb.2026.07.016_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.apsb.2026.07.016_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.07.016_bib28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1158\/2159-8290.CD-14-0763","article-title":"FGFR-mediated reactivation of MAPK signaling attenuates antitumor effects of imatinib in gastrointestinal stromal tumors","volume":"5","author":"Li","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2026.07.016_bib29","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1101\/gad.269415.115","article-title":"A majority of m6A residues are in the last exons, allowing the potential for 3\u2032UTR regulation","volume":"29","author":"Ke","year":"2015","journal-title":"Genes Dev"},{"key":"10.1016\/j.apsb.2026.07.016_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2026.07.016_bib31","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41388-022-02214-z","article-title":"m6A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression","volume":"41","author":"Lv","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2026.07.016_bib32","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1124\/mol.54.6.1036","article-title":"DNA-binding preferences of bisantrene analogues: relevance to the sequence specificity of drug-mediated topoisomerase II poisoning","volume":"54","author":"Sissi","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apsb.2026.07.016_bib33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2026.07.016_bib34","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2032UTRs and near stop codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.07.016_bib35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","article-title":"Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers","volume":"74","author":"Shi","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2026.07.016_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-Methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.016_bib37","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1136\/gutjnl-2015-309482","article-title":"SETD2 histone modifier loss in aggressive GI stromal tumours","volume":"65","author":"Huang","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2026.07.016_bib38","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-13-0092","article-title":"Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor","volume":"3","author":"Killian","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2026.07.016_bib39","doi-asserted-by":"crossref","first-page":"D43","DOI":"10.1093\/nar\/gkw965","article-title":"ChIPBase v2.0: decoding transcriptional regulatory networks of non-coding RNAs and protein-coding genes from ChIP-seq data","volume":"45","author":"Zhou","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2026.07.016_bib40","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.celrep.2014.05.026","article-title":"SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability","volume":"7","author":"Pfister","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.07.016_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2022.103407","article-title":"The role of histone H3K36me3 writers, readers and erasers in maintaining genome stability","volume":"119","author":"Sharda","year":"2022","journal-title":"DNA Repair"},{"key":"10.1016\/j.apsb.2026.07.016_bib42","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1126\/science.aac7557","article-title":"Gene essentiality and synthetic lethality in haploid human cells","volume":"350","author":"Blomen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.07.016_bib43","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.aac7041","article-title":"Identification and characterization of essential genes in the human genome","volume":"350","author":"Wang","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.07.016_bib44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cell.2017.07.005","article-title":"Project DRIVE: a compendium of cancer dependencies and synthetic lethal relationships uncovered by large-scale, deep RNAi screening","volume":"170","author":"McDonald","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.07.016_bib45","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/acsmedchemlett.2c00167","article-title":"Conformational-design-driven discovery of EZM0414: a selective, potent SETD2 inhibitor for clinical studies","volume":"13","author":"Alford","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2026.07.016_bib46","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2021-147967","article-title":"A phase 1\/1b open-label, multicenter, two-part study of SETD2 inhibitor EZM0414 in patients with relapsed\/refractory multiple myeloma or diffuse large B-cell lymphoma","volume":"138","author":"Richardson","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.07.016_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000599","article-title":"A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene","volume":"5","author":"Church","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.apsb.2026.07.016_bib48","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/labinvest.2009.78","article-title":"In vivo effect of imatinib on progression of cecal GIST-like tumors in exon 17-type c-kit knock-in mice","volume":"89","author":"Ishikawa","year":"2009","journal-title":"Lab Invest"},{"key":"10.1016\/j.apsb.2026.07.016_bib49","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.6004\/jnccn.2020.0058","article-title":"NCCN guidelines insights: soft tissue sarcoma, version 1.2021","volume":"18","author":"von Mehren","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.apsb.2026.07.016_bib50","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.6004\/jnccn.2022.0058","article-title":"NCCN guidelines insights: gastrointestinal stromal tumors, version 2.2022","volume":"20","author":"von Mehren","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.apsb.2026.07.016_bib51","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1470-2045(20)30168-6","article-title":"Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"21","author":"Blay","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.apsb.2026.07.016_bib52","doi-asserted-by":"crossref","first-page":"9153","DOI":"10.1158\/0008-5472.CAN-06-0165","article-title":"Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor","volume":"66","author":"Bauer","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2026.07.016_bib53","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1158\/0008-5472.CAN-08-4004","article-title":"Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumors","volume":"69","author":"Muhlenberg","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2026.07.016_bib54","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","article-title":"METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2026.07.016_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04329-y","article-title":"MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity","volume":"9","author":"Skucha","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.016_bib56","article-title":"Histone methyltransferase SETD2: an epigenetic driver in clear cell renal cell carcinoma","volume":"13","author":"Yu","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.apsb.2026.07.016_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-024-01546-5","article-title":"Small molecule inhibitors targeting m6A regulators","volume":"17","author":"Feng","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2026.07.016_bib58","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1021\/acs.jmedchem.4c02076","article-title":"Discovery of novel RNA demethylase FTO inhibitors featuring an acylhydrazone scaffold with potent antileukemia activity","volume":"68","author":"Liang","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.07.016_bib59","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(12)61857-1","article-title":"Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"381","author":"Demetri","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.07.016_bib60","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S1470-2045(13)70453-4","article-title":"Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial","volume":"14","author":"Kang","year":"2013","journal-title":"Lancet Oncol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:19:58Z","timestamp":1789600798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526004533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211383526004533"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.07.016","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the SETD2\u2013FTO\u2013KIT pathway as a pharmacological strategy for TKI-refractory GIST","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}